Article

Presbyopic laser vision correction reduces spectacle dependence in pseudophakes

San Francisco-Creation of a multifocal corneal is a safe and effective option for reducing spectacle dependence in eyes with pseudophakia implanted with a monofocal IOL, according to Gustavo Tamayo, MD, of Bogota Laser Refractive Institute, Bogota, Colombia.

San Francisco-Creation of a multifocal corneal is a safe and effective option for reducing spectacle dependence in eyes with pseudophakia implanted with a monofocal IOL, according to Gustavo Tamayo, MD, of Bogota Laser Refractive Institute, Bogota, Colombia.

Dr. Tamayo presented results from 22 eyes that underwent LASIK (four eyes) or LASEK with mitomycin C (18 eyes) using a wavefront-guided, multifocal procedure (CustomVue, Abbott Medical Optics) to correct residual refractive error and create a peripheral high-dioptric power zone for near vision.

Eligible patients underwent uncomplicated phacoemulsification at least 6 months earlier, had best-corrected visual acuity (BCVA) of 20/20, and a normal macular appearance. Nine eyes had hyperopic astigmatism, six eyes had myopic astigmatism, and seven had mixed astigmatism. All patients wore glasses for reading, 17 wore glasses for distance, and four wore contact lens correction.

All eyes experienced an improvement in near and distance uncorrected visual acuity and a significant reduction in dependence on spectacles occurred. Safety was favorable with no eyes losing distance BCVA, and halos and other visual symptoms only slightly increased after surgery. Patient satisfaction was very high, Dr. Tamayo said.

"Now, pseudophakic patients with a monofocal IOL implanted may be offered another option to receive the benefit of multifocality as is provided by premium IOLs," he concluded. "Placing multifocality on the cornea is safe and effectively reduces dependence on glasses."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.